ConductScience.org, home

Paper40022166

Neuronal guanine nucleotide exchange factor promotes the axonal growth and cancer cell proliferation via Ephrin-A3/EphA2 axis in lung adenocarcinoma.

Mi J and 6 others. J Transl Med, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Neuronal guanine nucleotide exchange factor promotes the axonal growth and cancer cell proliferation via Ephrin-A3/EphA2 axis in lung adenocarcinoma. Papers, record 40022166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40022166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neuronal guanine nucleotide exchange factor promotes the axonal growth and cancer cell proliferation via Ephrin-A3/EphA2 axis in lung adenocarcinoma.
PubMed
Journal
J Transl Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-09-24
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mi JJie
2Zhang WWentian
3Ren YYijiu
4Zhu LLei
5Yang BBei
6Wang HHao
7Duan LLiang

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenocarcinoma of LungMajor topic
Lung NeoplasmsMajor topic
AxonsMajor topic
Guanine Nucleotide Exchange FactorsMajor topic
Nerve Tissue ProteinsMajor topic
Humans
Cell Proliferation
Animals
Cell Line, Tumor
Signal Transduction
Gene Expression Regulation, Neoplastic
Female
Prognosis
Male
Mice
Mice, Nude

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
23YF1435500Shanghai Science and Technology Innovation Action PlanPubMed

Source PubMed

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135227773Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma.J Hepatol2022https://conductscience.org/library/papers/35227773PubMed
229363583Ephexin1 Is Required for Eph-Mediated Limb Trajectory of Spinal Motor Axons.J Neurosci2018https://conductscience.org/library/papers/29363583PubMed
337980488Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.J Transl Med2023https://conductscience.org/library/papers/37980488PubMed
433433946Cancer Statistics, 2021.CA Cancer J Clin2021https://conductscience.org/library/papers/33433946PubMed
534708571Implantable Electrical Stimulation at Dorsal Root Ganglions Accelerates Osteoporotic Fracture Healing via Calcitonin Gene-Related Peptide.Adv Sci (Weinh)2022https://conductscience.org/library/papers/34708571PubMed
627989802Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling.Cancer Cell2017https://conductscience.org/library/papers/27989802PubMed
729456630Roles of Eph/ephrin bidirectional signaling in central nervous system injury and recovery.Exp Ther Med2018https://conductscience.org/library/papers/29456630PubMed
832375579Calcitonin Gene-Related Peptide Enhances Distraction Osteogenesis by Increasing Angiogenesis.Tissue Eng Part A2021https://conductscience.org/library/papers/32375579PubMed
924030979Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.Cancer Res2013https://conductscience.org/library/papers/24030979PubMed
1023846904Autonomic nerve development contributes to prostate cancer progression.Science2013https://conductscience.org/library/papers/23846904PubMed
1138764064NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma.BMC Pulm Med2024https://conductscience.org/library/papers/38764064PubMed
1234969767Nerve Growth Factor in Breast Cancer Cells Promotes Axonal Growth and Expression of Calcitonin Gene-related Peptide in a Rat Model of Spinal Metastasis.Anticancer Res2022https://conductscience.org/library/papers/34969767PubMed
1332302564Roadmap for the Emerging Field of Cancer Neuroscience.Cell2020https://conductscience.org/library/papers/32302564PubMed
1433288884Nerve fibers in the tumor microenvironment in neurotropic cancer-pancreatic cancer and cholangiocarcinoma.Oncogene2021https://conductscience.org/library/papers/33288884PubMed
1535627236A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.Genes (Basel)2022https://conductscience.org/library/papers/35627236PubMed
1630682817Emerging Roles of Ephexins in Physiology and Disease.Cells2019https://conductscience.org/library/papers/30682817PubMed
1732473645LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression.Mol Cancer2020https://conductscience.org/library/papers/32473645PubMed
1835941690Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma.J Exp Clin Cancer Res2022https://conductscience.org/library/papers/35941690PubMed
1919361476Dehydroepiandrosterone and neurotrophins favor axonal growth in a sensory neuron-keratinocyte coculture model.Neuroscience2009https://conductscience.org/library/papers/19361476PubMed
2038778601Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm.Curr Gene Ther2025https://conductscience.org/library/papers/38778601PubMed

See all 40 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41361459KIF4A in disease pathogenesis and therapeutics: from molecular mechanisms to clinical translation.Biol Direct2025https://conductscience.org/library/papers/41361459PubMed
41178927Neuro-tumor interactions: Multi-dimensional mechanisms of neurotransmitter regulation in tumor immune evasion and metabolic reprogramming.World J Clin Oncol2025https://conductscience.org/library/papers/41178927PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EFNA31944PubTator's text mininghttps://conductscience.org/library/genes/1944NCBI Gene
EPHA21969PubTator's text mininghttps://conductscience.org/library/genes/1969NCBI Gene
KIF4A24137PubTator's text mininghttps://conductscience.org/library/genes/24137NCBI Gene
NGEF25791PubTator's text mininghttps://conductscience.org/library/genes/25791NCBI Gene
PABPC126986PubTator's text mininghttps://conductscience.org/library/genes/26986NCBI Gene
UCHL17345PubTator's text mininghttps://conductscience.org/library/genes/7345NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40022166

GET https://conductscience.org/api/papers/v1/40022166/references?page=2